Note: Descriptions are shown in the official language in which they were submitted.
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
LOW PROTEIN PERCENTAGE GELLING COMPOSITIONS
1. FIELD OF THE INVENTION
10011 This invention relates to compositions of keratin protein-based
biomaterials and methods
of making thereof.
2. BACKGROUND OF THE INVENTION
[002] Keratins are a family of proteins found in the hair, skin, and other
tissues of vertebrates.
Hair is a unique source of human keratins because it is one of the few human
tissues that are
readily available and inexpensive. Although other sources of keratins are
acceptable feedstocks
for the present invention (e.g. wool, fur, horns, hooves, beaks, feathers,
scales, and the like),
human hair is preferred because of its biocompatibility in human medical
applications.
[003] Keratins can be extracted from human hair fibers by oxidation or
reduction using
methods that have been widely published in the art. If one employs a reductive
treatment, the
resulting keratins are referred to as kerateines. If an oxidative treatment is
used, the resulting
keratins are referred to as keratoses. These methods typically employ a two-
step process
whereby the crosslinked structure of keratins is broken down by either
oxidation or reduction. In
these reactions, the disulfide bonds in cystine amino acid residues are
cleaved, rendering the
keratins soluble without appreciable disruption of amide bonds. Many of the
keratins can remain
trapped within the cuticle's protective structure, so a second-step using a
denaturing solution is
typically employed to effect efficient extraction of the cortical proteins
(alternatively, in the case
of oxidation reactions, these steps can be combined). This step has also been
widely published in
the art as solutions such as urea, transition metal hydroxides, surfactant
solutions, and
combinations thereof have been employed. Common methods employ the use of
aqueous
solutions of tris(hydroxymethyl) aminomethane in concentrations between 0.1
and 1.0M, and
urea solutions between 0.1 and 10M.
[004] When oxidation is selected as the extraction method of choice, strong
oxidants are used
to cleave the cystine amino acid and solubilize the keratin proteins. A
preferred oxidant is
peracetic acid. Peracetic acid (CH3C000H) hydrolyzes into acetic acid
(CH3COOH) and
1
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
hydrogen peroxide (H202). It also undergoes homolysis to produce peroxyl
(CH3C00-;
CH3C000"), hydrogen (H4), and hydroxyl (HO) radicals. Hydroxyl radicals are
very strong
oxidizing agents due to their high standard reduction potential (2310 mV).
When reacted with
HO-, proteins decompose into fragments with carbonyl groups (-C=0) in the
presence of oxygen
(02) and a small fraction forms protein aggregates via cross-linking. Both of
these degraded and
cross-linked forms are observed in keratose samples. Aside from oxidation of
cystine, peracetic
acid (most likely through the action of HO- and H202)) also reacts and
modifies other amino
acids of the protein chain. The free thiols (-SH) of cysteines are converted
to sulfenic acid (-
SOH), which are further oxidized into sulfinic (-S02H) and sulfonic acid
derivatives.
10051 The ability to form a polymerized hydrogel is an important feature in
biomaterials used as
scaffolds for cells, agents for drug delivery or constructs to promote cell
infiltration and tissue
remodeling. Hydration of lyophilized keratose materials generally yields the
formation of an
elastic solid-like hydrogel at high solute concentrations (200 mg/ml in PBS).
Rheological
properties of these gels as well as their chemistries indicate that the
primary mechanism of
gelation is through polymer chain entanglement. Oxidation of free thiols
eliminates the ability of
oxidized keratins to reassemble via covalent disulfide bonding. Instead, other
gelation
determinant factors may include electrostatic and hydrophobic interaction.
Keratin multimers
may form a larger network through electrostatic attraction as suggested in the
assembly of
intermediate filament molecules in which the head (positive) and the tail
(negative) domains of
dimers potentially associate to form a tetramer. The negatively-charged
sulfonic acid groups can
also interact with the basic amino acid residues such as lysine, arginine, and
histidine that
escaped oxidation. Additionally, the coil regions of keratins that are rich in
hydrophobic
sequences may aggregate together to increase the polymer molecular weight and
promote
gelation.
[006] Previously described compositions of keratin-based hydrogels have been
reported.
However, many of the hydrogels rely on relatively high protein percentages to
establish and
maintain the structure of the hydrogel. Accordingly, there is a great need to
prepare
compositions that form and maintain hydrogels at low protein percentages.
2
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
3. SUMMARY OF THE INVENTION
1007] Disclosed herein are compositions of keratin-based biomaterials that
form hydrogels at
low protein percentages and uses thereof.
[008] Also disclosed herein are compositions, and methods of making
compositions,
comprising keratose, keratein, or a combination thereof, wherein said
composition forms a
hydrogel at a protein concentration of less than 20%.
4. BRIEF DESCRIPTION OF THE FIGURES
[009] Figure 1 depicts the theological properties of 10% keratose samples that
behave as
hydrogels. These data show that 10% keratose samples exhibit hydrogel
properties as they
exhibit constant G' and G" values as the frequency is varied.
[0010] Figure 2 depicts SDS-polyacrylamide gel representing alpha-keratose
preparations at
three different loading concentrations (50/100/150 jig/lane).
[0011] Figure 3 Alpha-kerateine (KTNA) was subjected to SDS-PAGE analysis at a
loading
concentration of 45 11g/lane. The image of the gel indicates the high purity
of the sample and the
presence of different species of multimers of kerateine present in the same.
The multimers
present are not disrupted by the SDS-PAGE analysis.
[0012i Figure 4 represents the results from a gelation assay with alpha-
keratose samples
prepared as described herein. Hydrogels are formed at 2%, 4%, 7%, 10%, and 15%
alpha-
keratose (A., KSOA= alpha-keratose). Presented in B is an example of a
keratose sample that
has failed the gelation assay for comparison.
5. DETAILED DESCRIPTION
[0013i "Keratin protein source" as used herein includes proteinaceous sources
of keratin proteins
including but not limited to human or animal hair, wool, fur, horns, hooves,
beaks, feathers,
scales, and the like.
[0014] "Keratin protein(s)" as used herein collectively refers to keratin in
keratin protein
sources, including but not limited to naturally occurring keratin, reduced
keratin, and/or oxidized
keratin, or S-sulfonated keratin. This term also refers to the extracted
keratin derivatives that are
3
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
produced by oxidative and/or reductive treatment of keratin, including but not
limited to
keratose, alpha-keratose, gamma-keratose, kerateine, alpha-kerateine, or gamma-
kerateine.
[0015] Keratin protein sources
Keratins are a family of proteins found in the hair, skin, and other tissues
of vertebrates. Hair is a
common source of human keratins because it is one of the few human tissues
that are readily
available and inexpensive. Other sources of keratins are acceptable feedstocks
for the present
invention, (e.g., wool, fur, horns, hooves, beaks, feathers, scales, and the
like). Human hair is
often used with human subjects because of its biocompatibility. Accordingly,
in some
embodiments, human hair is the keratin protein source. The human hair can be
end-cut, as one
would typically find in a barber shop or salon.
[0016] Keratin proteins
Soluble keratins can be extracted from human hair fibers by oxidation or
reduction using
methods known in the art. These methods typically employ a two-step process
whereby the
crosslinked structure of keratins is broken down by either oxidation or
reduction. In these
reactions, the disulfide bonds in cystine amino acid residues are cleaved,
rendering the keratins
soluble. The cuticle is essentially unaffected by this treatment, so the
majority of the keratins
remain trapped within the cuticle's protective structure. In order to extract
these keratins, a
second step using a denaturing solution is employed. Alternatively, in the
case of reduction
reactions, these steps can be combined. Denaturing solutions known in the art
include urea,
transition metal hydroxides, surfactant solutions, and combinations thereof.
Common methods
use aqueous solutions of tris base (2-Amino-2-(hydroxymethyl)- l,3-
propanediol) in
concentrations between 0.1 and 1.0 M, and urea solutions between 0.1 and 10M,
for oxidation
and reduction reactions, respectively.
[0017] If one employs an oxidative treatment, the resulting keratins are
referred to as
"keratoses." If a reductive treatment is used, the resulting keratins are
referred to as "kerateines."
[0018] Crude (unfractionated) extracts of keratins, regardless of redox state,
can be further
refined into matrix (KAP and gamma), alpha, and/or charged (acidic or basic)
fractions by a
variety of methods such as isoelectric precipitation, dialysis, or high
performance liquid
chromatography (HPLC), as desired. In a crude extract, the alpha fraction
begins to precipitate
below pH 6 and is essentially completely precipitated by pH 4.2.
4
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
100191 In some embodiments, KAP co-precipitate with the alpha fraction,
thereby producing an
alpha/KAP mixture.
100201 High molecular weight keratins, or "alpha keratins," (alpha helical),
are thought to
originate from the microfibrillar regions of the hair follicle, and typically
range in molecular
weight from about 40-85 kiloDaltons. Low molecular weight keratins, or "gamma
keratins," or
keratin-associated proteins (KAPs, globular), are thought to originate from
the matrix regions of
the hair follicle, and typically range in molecular weight from about 3-30
kiloDaltons for KAP
and 10-15 kiloDaltons for gamma keratins
100211 In some embodiments, the keratin preparations (particularly alpha-
keratose or alpha-
kerateine) have average monomeric molecular weights of from about 45 to about
70 kiloDaltons.
Gamma-keratoses and Gamma-kerateines have average molecular weights between 10
and 25
kiloDaltons and form complexes with alpha keratins. The alpha keratins
extracted and described
herein exist as obligate heterodimers that are complexed alpha keratin
monomers with higher
average molecular weights, e.g., up to 100 or 200 or 300 or 400 or 500
kiloDaltons. These
combinations when complexed (e.g. alpha keratose, gamma keratose, alpha
kerateine, gamma
kerateine or combinations thereof) are termed "metakeratins".
100221 Even though alpha and gamma keratins possess unique properties, the
properties of
subfamilies of both alpha and gamma keratins can only be revealed through more
sophisticated
means of purification and separation such as provided herein. Additional
properties that are
beneficial emerge and can be optimized upon further separation and
purification of crude keratin
extracts.
100231 Keratose Production
One method for the production of keratoses is by oxidation of keratin with
hydrogen peroxide,
peracetic acid, or performic acid. In a specific embodiment, the oxidant is
peracetic acid.
Generally, a solution of peracetic acid is used at a concentration range of
about 1% to about
10%. A specific concentration used can be a 2% solution of peracetic acid. In
some
embodiments, the oxidant concentrations range from a ratio of about 5:1 to
about 50:1 weight to
weight to the keratin protein source to be extracted. A specific embodiment
uses a weight to
weight ratio of 25:1 of a 2% peracetic acid solution. Those skilled in the art
will recognize that
slight modifications to the concentration can be made to affect varying
degrees of oxidation, with
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
concomitant alterations in reaction time, temperature, and liquid to solid
ratio. It has also been
discussed by Crewther et at. that performic acid offers the advantage of
minimal peptide bond
cleavage compared to peracetic acid. However, peracetic acid offers the
advantages of cost and
availability. In some embodiments, the oxidation temperature is between 0 and
100 Celsius. In a
specific embodiment, the oxidation temperature is 37 C. In some embodiments,
the oxidation
time is between 0.5 and 24 hours. In a specific embodiment, the oxidation
time' is 12 hours. In
some embodiments, mechanical mixing is used to maximize oxidation efficiency.
Additional
yield can be achieved with subsequent extractions with dilute solutions of
oxidant, or water.
After oxidation, the keratin protein source can be rinsed free of residual
oxidant using purified
water. In some embodiments, the oxidized keratin protein source is washed with
water until
residual oxidant is removed. In some embodiments, the washing step is
performed until the
washed keratin protein source does not test positive for oxidant.
[0024] The keratoses may be extracted from the oxidized keratin protein source
using an
aqueous solution of a denaturing agent. Protein denaturants are well known in
the art, including
but not limited to, urea, transition metal hydroxides (e.g. sodium and
potassium hydroxide),
ammonium hydroxide, and tris(hydroxymethyl)aminomethane (Tris, also known as
Trizma
base). In some embodiments, Tris is used at a ratio of about 5:1 to about 50:1
weight of protein
source, to a Tris solution of a concentration of about 0.01 to 1M. In a
specific embodiment, the
ratio is 25:1. In another specific embodiment, Tris is used at a concentration
of 100mM. Those
skilled in the art will recognize that slight modifications to the
concentration can be made to
effect varying degrees of extraction, with concomitant alterations in reaction
time, temperature,
and liquid to solid ratio. In some embodiments, the extraction temperature is
between 00 and
100 C. In a specific embodiment, the extraction temperature is 37 C. In some
embodiments, the
extraction time is between 0.5 and 24 hours. In a specific embodiment, the
extraction time is
about 2 hours. Additional yield can be achieved with subsequent extractions
with dilute solutions
of Tris or purified water. Often, the extraction is performed with mechanical
agitation in a
mixing tank to ensure a more efficient yield.
100251 Kerateine Production
Similar to the methods described above for extraction and purification of
keratoses, kerateines
can be produced by reduction of a keratin protein source with thioglycolic
acid or beta-
6
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
mercaptoethanol. Specifically, thioglycolic acid (TGA) is often used. In some
embodiments,
TGA is added to the keratin protein source at a ratio of about 5:1 to about
50:1. In a specific
embodiment, TGA is added at a ratio of 25:1. The TGA is added at a solution
ranging in
concentrations from about 0.1 to about 10M. In a specific embodiment, the TGA
is added in
solution at a concentration of 0.5M. During extraction, mechanical agitation
is used to maximize
extraction efficiency.
[0026] The solution containing reductant and extracted kerateine proteins
(soluble keratin
protein solution) is the collected and stored by straining the keratin protein
source through a 400
micron mesh and storing the solution at 4 C. A base is then added to the
drained keratin protein
source in a ratio of about 10:1 to about 50:1. In a specific embodiment, the
base is added to the
drained keratin protein source at a ratio of 25:1. In some embodiments, the
base is Tris generally
used at a concentration of about 100 mM. The keratin protein source in the
solution with base is
mixed with agitation of about 2 hours at 37 C. The solution containing the
base and extracted
keratin proteins (soluble keratin protein solution) is then filtered through a
added to the first
extracted solution and stored
10027] Those skilled in the art will recognize that slight modifications to
the concentration can
be made to effect varying degree of reduction, with concomitant alterations in
pH, reaction time,
temperature, and liquid to solid ratio. In some embodiments, the reduction is
performed at a
temperature between 0 and 100 C. In a specific embodiment, the temperature is
37 C. In some
embodiments, the reduction time is between 0.5 and 24 hours. In a specific
embodiment, the
reduction is performed for 15 hours. Unlike the previously described oxidation
reaction,
reduction is carried out at basic pH. Keratins are highly soluble in a
reduction media and are
expected to be extracted. The reduction solution may therefore be combined
with the subsequent
extraction solutions and processed accordingly. The reduction is carried out
with mechanical
agitation in a mixing tank to increase the efficiency of the reduction of the
keratin proteins.
[0028] Residual reductant and denaturing agents can be removed from solution
by dialysis.
Typical dialysis conditions are 1 to 2% solution of kerateines dialyzed
against purified water.
Those skilled in the art will recognize that other methods exist for the
removal of low molecular
weight contaminants in addition to dialysis (e.g. microfiltration,
chromatography, and the like).
Once dissolved, the kerateines are stable in solution without the denaturing
agent for finite
7
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
periods. Therefore, the denaturing agent can be removed without the resultant
precipitation of
kerateines. Regardless of the fractionation/purification process, the
resulting kerateines can be
concentrated and lyophilized, similar to keratoses.
[0029] A soluble keratin protein solution is produced by the extraction of
keratose and/or
kerateine by either oxidative means for keratose, or by reductive means for
kerateine.
[0030] High speed centrifugation
In order to remove many of the keratin associated proteins and other proteins
extracted through
either oxidative or reductive processes listed above, a high speed
centrifugation step is used.
Current methods known in the art generally use a low speed centrifugation
(around 4,000 rpm) to
clear particulate matter. However, this speed does not create enough force to
remove many of
the beta keratin protein contaminants present in the extracted protein
solution. Thus, in some
embodiments, high speed centrifugation is employed. Speeds in excess of about
5,000 rpm to
about 30,000 rpm can be used. In a specific embodiment, the extracted protein
solution is spun
at about 20,000 rpm to produce a clarified protein solution of solubilized
keratin proteins. In
another specific embodiment, the high speed centrifugation step is performed
at about 4 C.
[0031] A clarified protein solution is produced by the high speed
centrifugation of the soluble
keratin protein solution.
[0032] Dialysis
In many instances during protein purification, dialysis is used to separate or
even to concentrate
certain protein species present in the sample. Accordingly here, in many
embodiments, the
clarified protein solution is subjected to a dialysis step to fractionate
certain protein species. In
some embodiments, a 100 IcDa molecular weight cutoff membrane is employed in
the
purification of alpha-keratose or alpha-kerateine. In other embodiments, a 5
kDa molecular
weight cutoff membrane is employed to purify gamma-keratose or gamma
kerateine. A common
matrix for the dialysis membranes is regenerated cellulose, however, many
other membrane
preparations suitable for protein purification may be used.
[0033] In many instances, pressure is applied to aid in the dialysis process.
If the pressure
applied is too low, the resultant solutions contain greater protein fragments
and peptides.
Conversely, if the pressure is too high, the result is protein complex
degradation. Thus, in some
embodiments, the dialysis is performed under conditions that maintain a
transmembrane pressure
8
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
from about 30 to about 70 psi. In some embodiments the transmembrane pressure
is about 30 to
about 40 psi, in others it is about 60 to about 70 psi. Further, it is
important to minimize the heat
buildup developed by the shear stress of pressurized dialysis. Thus, in some
embodiments, the
dialysis is carried out at a temperature from about 4 C to about 20 C. In a
specific
embodiment, the dialysis is carried out at about 15 C.
[0034] Additionally, as the solution is dialyzed, the conductivity is
adjusted. In some
embodiments, the conductivity is adjusted down to about or below 0.6 mS. In
some instances,
the conductivity is adjusted with water.
100351 Lyophilization
Storage of proteins for any length of time can pose stability problems. Since
proteins are
generally more stable at colder temperatures, maintenance at low temperatures
even for short
duration is recommended. Typically, proteins can be freeze-dried (lyophilized)
to achieve
storage conditions while maintaining protein stability.
[0036) In some embodiments, lyophilization is used to produce a protein cake
of purified
protein. The lyophilization is used to stabilize the extracted keratin
proteins. Methods known in
the art such as shell freezing followed by vacuum or bulk freezing and
applying high heat tend to
degrade proteins. Accordingly, in some embodiments, a keratin protein cake,
comprising
keratose alpha or gamma and/or kerateine alpha or gamma is produced by a
lyophilization of a
clarified keratin protein solution, optionally after dialysis.
[0037] In some embodiments, the clarified protein solution post-dialysis is
bulk frozen at about -
40 C, and then a vacuum is applied until the containment containing the
solution reaches about
250 torr. In some embodiments, heat is then applied in a step-wise fashion,
bringing the material
to about 0 C, then to about 25 C, then to about 37 C, while maintaining 250
ton pressure. In
some embodiments, the lyophilization process occurs over a 24 hour period.
[0038] Grinding
Precise grinding of the lyophilized material aids in the homogeneity of
reconstitution and protein
stability. Previous methods involve crude grinding methods, including grinding
or chopping of
the material in a laboratory blender. In the present invention, some
embodiments employ a
commercial grinding apparatus to machine the material to a homogenous particle
size. In some
9
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
embodiments, a pharmaceutical mill is employed. In other embodiments, the
particle size is
about 1000 microns or less in diameter.
100391 It is also important to remove the static charge from the ground
material to make it easier
to work with. Accordingly, in some embodiments, the ground material has been
deionized.
[0040] Hydrogel preparation
Hydrogels were prepared for analysis by carefully weighing the appropriate
keratin lyophilized
powder or powders. The powders were diluted in either sterile phosphobuffer
saline or sterile
water to generate the described percent mass to volume ratio. These solutions
were placed in a
37 C incubator overnight before analysis.
100411 In some embodiments, the hydrogel comprises less than 20% protein in a
weight to
volume ratio. In other embodiments, the hydrogels comprise less than 19%
protein, less than
18%, less than 17%, less than 16%, less than 15%, less than 14%, less than
13%, less than 12%,
less than 11%, less than 10%, less than 9%, less than 8%, less than 7%, less
than 6%, less than
5%, less than 4% protein, or less than 3% in a weight to volume ratio.
[0042] In other embodiments, the hydrogel comprises about 2%, about 3%, about
4%, about 5%,
about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about
13%, about
14%, about 15%, about 16%, about 17%, about 18%, or about 19% protein in a
weight to volume
ratio. In other embodiments, the hydrogel comprises 2%, 3%, 4%, 5%, 6%, 7%,
8%, 9%, 10%,
11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, or 19% protein in a weight to volume
ratio.
[0043] In some embodiments, the hydrogel may comprise 80%, 85%, 90%, 95%, 99%
or more
keratose. The keratose may be alpha-keratose or gamma-keratose, or some
combination thereof
In some embodiments, the keratose in the hydrogel comprises 50%, 55%, 60%,
65%, 70%, 75%,
80%, 85%, 90%, 95%, 99% or more alpha- keratose. In other embodiments, the
hydrogel
comprises 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 99% or more gamma-
keratose. In alternative embodiments, the hydrogel is substantially free of
gamma-keratose. In
some embodiments, the hydrogel is substantially free of kerateine. In other
embodiments,
keratose-based hydrogels are substantially free of disulfide bonds.
[0044] In some embodiments, the hydrogel may comprise 80%, 85%, 90%, 95%, 99%
or more
kerateine. The kerateine may be alpha-kerateine or gamma-kerateine, or some
combination
thereof In some embodiments, the kerateine in the hydrogel comprises 50%, 55%,
60%, 65%,
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
70%, 75%, 80%, 85%, 90%, 95%, 99% or more alpha- kerateine. In other
embodiments, the
hydrogel comprises 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 99% or
more
gamma-kerateine. In alternative embodiments, the hydrogel is substantially
free of gamma-
kerateine. In other embodiments, the hydrogel is substantially free of alpha
or gamma keratose.
(0045] In yet other embodiments, the hydrogels described herein present
similar gelation and
stability properties of gels of higher percentage protein concentration then
have been reported.
In some embodiments, compositions of the invention comprise hydrogels of less
than 20%
protein that exhibit similar gelation and/or stability properties than
hydrogels reported in the art
that comprise 20% or more protein. In other embodiments, compositions of the
invention
comprise hydrogels of less than 20% protein that exhibit superior gelation
and/or stability
properties than hydrogels reported in the art that comprise 20% or more
protein.
100461 In other embodiments, methods of the invention comprise making
hydrogels of less than
20% protein. Preparing a hydrogel is described above by may comprise the
following steps: a)
providing keratose, kerateine, or a combination thereof, at a concentration of
less than 20%
weight to volume in an aqueous medium; b) mixing said keratose, kerateine, or
a combination
thereof in said aqueous medium; and c) allowing the hydrogel to form.
Sometimes, the keratose,
kerateine, or a combination thereof has previously been lyophilized. Also, the
keratose,
kerateine or a combination thereof is provided as a ground protein powder.
100471 Also, the hydrogels described herein do not require additional
biomaterials or added
crosslinkers to create or maintain structure. Thus, the compositions presented
herein are
substantially free of added biomaterials or crosslinkers. Such biomaterials
and or crosslinkers
include, but are not limited to: albumin, (hydroxyethyl)starch, poly-
aspartamide, poly(vinyl
alcohol), hyaluronic acid, alginate, chitosan, collagen, gelatin, fibrin,
silk, poly(ethylene glycol)
(aka PEG), poly(lactic acid) (aka PLA), poly(lactic-co-glycolic acid) (aka
PLGA), poly(glycolic
acid) (aka PGA), poly(dioxanone), poly(caprolacetone), poly(PCPP-SA
anhydride), poly(2-
hydroxyethyl methacrylate) (aka pHEMA), dextran, dextran plus
glycidylmethacrylate (GMA),
cylco-dextran, dioleyl phosphatidylethanolamine (DOPE) and other catatonic
lipids forming
nanoparticles, calcium sulphates (bone powders/pastes), glutaraldehyde, 1-
ethy1-3-(3-
dimethylaminopropyl) carbodiimide) (aka EDC),
methylenebi sacrylamide,
hexamethylenediisocyanate, 1,4-bis(acryloyl)piperazine, 1,4-
cyclohexanedimethanol divinyl
11
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
ether, 1,4-phenylenediacryloyl chloride, 1,6-hexanediol diacrylate, N-(1-
hydroxy-2,2-
dimethoxyethyl)acrylamide, di(ethylene glycol) diacrylate, di(ethylene glycol)
dimethacrylate,
ethylene glycol diacrylate, ethylene glycol dimethacrylate, divinylbenzene,
genipin or other
common biomaterials or crosslinking agents or agents that are used to bolster
structure known in
the art. Additional hydrogel forming compositions are described in U.S. Patent
No. 5,854,382.
6. EXAMPLES
6.1 Example 1 -Keratose extraction methods (oxidative extraction) and
preparation of
keratose hydrogels.
[0048] Untreated Chinese hair was used in the extraction method. The hair was
cut to lengths of
1/4, 'A, 1/4 and 1 inch segments and washed in a warm water solution.
[0049] Step 1: The hair was added to a mixing tank. The tank was a vessel that
contained a
propeller for mechanical agitation. The oxidant was added to the vessel. The
oxidant used was a
2% solution of peracetic acid (PAA) at a 25:1 weight-to-weight ratio. The
mixture was
mechanically mixed for a period of 12 hours at 37 C.
[0050] Step 2: The residual solution containing the oxidant was drained,
neutralized and
discarded.
[0051] Step 3: The oxidized hair was collected and rinsed with water until PAA
test strips
revealed no residual oxidant in the solution.
[0052] Step 4: A base was then added to the drained hair in a ratio of 25:1.
In this Example, a
100mM Tris base was used. The solution was mixed with mechanical agitation in
the mixing
tank for 2 hours at 37 C.
[00531 Step 5: The solution containing base and extracted keratin proteins was
then collected
and stored in a separate container at 4 C. The remaining hair was retained by
sieving through a
steel mesh with a pore size of the mesh of 400 microns.
[0054] Step 6: Purified water was then added to the hair at a ratio of 25:1
and mixed for 2 hours
at 37 C.
12
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
[0055] Step 7: The solution containing water and extracted keratin proteins
was then collected
and added to the solution from Step 5 in a separate container stored at 4 C.
In order to get the
maximum extraction yield, the hair was sieved through a steel mesh with a pore
size of 400
microns.
[0056] Step 8: The combined mixture from Step 5 and Step 7 was then
centrifuged at 20,000
rpm to remove any solids or beta-keratins.
[0057] Step 9: The centrifuged solution was filtered with a 20 micrometer pore
size capsule
filter.
100581 Step 10: The solution from Step 9 was dialyzed against a 100 kDa
molecular weight cut
off dialysis membrane, made from regenerated cellulose, using standard
tangential flow
filtration. The solution was cooled to dissipate the heat from shear forces on
pumps. Also, trans-
membrane pressures were maintained between 30-40 psi during the dialysis
process. The
solution was dialyzed until the conductivity reached 0.6 mS using additions of
purified water to
replace permeate. The first complete solution wash was collected and stored in
a storage tank at
4 C.
[0059] Step 11: The solution from Step 10 was then lyophilized into a keratin
protein cake of
alpha keratose. The solution was bulk frozen to -40 C quickly then had a
vacuum applied until
the containment vessel containing the protein reached 250 torr. Heat was then
applied in a step-
wise fashion to bring the material first to 0 C, then to 25 C, then to 37 C
while maintaining 250
ton.
[0060] Step 12: The keratin protein cake from Step 12 was ground using a
pharmaceutical mill
with mesh sizes of 500 or 1000 microns. The ground protein was deionized to
better allow
further processing. The ground protein was then placed in sterile bags to be
stored prior to
reconstitution.
100611 Preparation of keratose hydrogels
Keratose hydrogels were prepared for analysis by carefully weighing the
appropriate keratin
lyophilized powder. The powders were diluted in either sterile phosphobuffer
saline or sterile
water to generate the described percent mass to volume ratio. These solutions
were placed in a
37 C incubator overnight before analysis.
13
CA 0 2 8 4 5 2 67 2 01 4-0 2-1 3
WO 2013/025941 PCT/US2012/051215
[0062] For rheological data, two measurements were performed on a Bohlin CS-10
Rotational
Rheometer. Solutions that were able to flow from the incubation tubes were
measured in a
14rnm cup and bob apparatus. Solutions that were too complexed to flow were
measured
between a 20mm plate and plate apparatus with a 15mm gap. All measurements
were performed
at 25 C. Preliminary stress sweep test were performed on each sample to
determine the linear
region within the viscoelastic response. The frequency dependence of the
viscoelastic properties
of the keratose gels were measured at 25 Pa. The elastic modulus, viscous
modulus, and
complex viscosity were measured and reported in Table 1, below.
[0063] Table 1: Rheological values of keratose gels (n=3)
20% from de Guzeman et al. 2011 10% 15%
Frequency
(Hz) 0.1 1 0.1 1 0.1 1
GI Pa) 164.94+/-86.19 215.70+1-91.30 72.0+1-7.4 95.7+/-3.9
675.9+/-34.6 811.0+1-2.7
G(Pa) 162.53+/-86.20 210.97+/-91.12 68.4+/-7.0 95.7+/-3.4 669.4+/-38.6 801.9+1-
5.8
G(Pa) 27.48+/-7.40 44.22+1-10.48 22.4+1-2.4 25.1+1-1.5
889.8+1-28.9 119.0+1-22.7
n*(Pas) 262.53+1-137.22 34.33+/-14.57 114.5+/-11.7 13.9+1-0.6 1075.3+1-54.7
113.9+1-0.2
[0064] Presented in Table I are the rheological values for a 20% keratose gel
from de Guzeman
et al. 2011 (lanes 1 and 2), and keratose hydrogels prepared as in this
example at 10% keratose
(lanes 3 and 4) and at 15% (lanes 5 and 6). Of note, the rheological data
reported from de
Guzeman et al. demonstrated very high standard deviations versus the values
for all the materials
tested from the material described herein. The high variability in the gels
reported from de
Guzeman suggests that the structure is not uniform throughout the different
samples.
Conversely, the data for 10% gels prepared as presented herein produces very
small standard
deviations when the various rheological parameters are tested. The 10%
keratose gels exhibited a
very low standard deviation in measurements for dynamic complex modulus (G*),
dynamic
elastic/storage modulus (G'), dynamic complex viscosity (11`), and dynamic
viscous/loss
modulus (G"). These data demonstrated that the 10% hydrogels produced herein
exhibit a more
uniform, stable structure than the 20% gels reported in the art. Further, the
data for 15% gels
prepared as presented herein exhibited very small standard deviations when the
various
rheological parameters are tested. The 15% keratose gels exhibited a very low
standard deviation
in measurements for dynamic complex modulus, dynamic elastic/storage modulus,
dynamic
14
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
complex viscosity, and dynamic viscous/loss modulus. These data demonstrate
that the 15%
hydrogels produced herein also exhibit a more uniform, stable structure than
the 20% gels
reported in the art.
6.2 Example 2 Kerateine extraction methods (reductive extraction) and
preparation of
kerateine hydrogels.
[0065] Untreated Chinese hair was end-cut to lengths of 1/4, 1/2, 1/4 and 1
inch segments and
washed in a warm water solution.
100661 Step 1: The hair was added to a vessel that contained a propeller for
mechanical agitation.
The reductant was added to the vessel. The reductant was a 0.5M solution of a
thioglycolic acid
(TGA) at a ratio of 25:1. The mixture was mechanically mixed for a period of
15 hours at 37 C.
[0067j Step 2: The solution containing reductant and extracted keratin
proteins was collected and
stored in a separate container at 4 C. The remaining hair was retained by
sieving through a steel
mesh with a pore size of 400 microns.
[0068] Step 3: A base was then added to the drained hair in a ratio of 25:1.
The base used here
was a 100mM Tris base solution. The solution was mixed with mechanical
agitation in a mixing
tank for 2 hours at 37 C.
[0069] Step 4: The solution containing base and extracted keratin proteins was
collected and
added to the solution from Step 2 and stored at 4 C. The remaining hair was
retained by sieving
through a steel mesh with a pore size of 400 microns.
[00701 Step 5: Purified water was added to the hair at a ratio of 25:1 and
mixed for 2 hours at
37 C.
[0071] Step 6: The solution containing water and extracted keratin proteins
was collected as in
Step 4 and added to the solution from Step 4 and stored at 4 C. Sterile water
was added to the
hair at a ratio of 40:1 and mixed for 2 hours at 37 C.
10072] Step 7: A second reduction step was needed to fully extract the keratin
proteins from the
hair shaft. The reductant used was a 0.5M solution of a thioglycolic acid
(TGA) at a ratio of
25:1. The mixture was mechanically mixed for a period of 15 hours at 37 C.
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
[0073] Step 8: The solution containing reductant and extracted keratin
proteins was collected and
stored in a separate vessel containing the solution from Step 6 and stored at
4 C. The remaining
hair was retained by sieving through a steel mesh with a pore size of 400
microns. Mechanical
agitation applied during the straining process helps to strain as much
solution from the hair mass.
100741 Step 9: A base was added to the drained hair in a ratio of 25:1. The
base used was a
100mM Tris base solution. The solution was mixed with mechanical agitation in
a mixing tank
for 2 hours at 37 C.
[0075] Step 10: The solution containing base and extracted keratin proteins
was then collected
and added to the solution from Step 8 and stored at 4 C. The remaining hair
was retained by
sieving through a steel mesh with a pore size of 400 microns. Mechanical
agitation applied
during the straining process helps to strain as much solution as possible from
the hair mass.
[0076] Step 11: Purified water was then added to the hair at a ratio of 10:1
and mixed for 2 hours
at 37 C.
[0077] Step 12: The solution containing water and extracted keratin proteins
was collected and
added to the solution from Step 10 stored at 4 C. In order to get the maximum
extraction yield,
the hair was sieved through a steel mesh of a pore size of 400 microns.
10078] Step 13: The combined mixture from Steps 12, 10, 8, 6, 4, and 2 was
centrifuged at
20,000 rpm to remove any solids or beta keratins.
[0079] Step 14: The centrifuged solution was filtered with a 20 micrometer
pore size capsule
filter.
[0080] Step 15: The solution from Step 14 was dialyzed against a 100 kDa
molecular weight cut
off regenerated cellulose dialysis membrane using standard tangential flow
filtration methods.
The solution was cooled to dissipate the heat from shear forces on pumps.
Also, trans-membrane
pressures were maintained between 50-60 psi during the dialysis process. The
solution was
dialyzed until the conductivity lowered from about 24 mS to about 0.6 mS using
additions of
purified water to replace permeate. This required about 5 complete volume
changes (or washes)
and left some residual TGA in the solution. The TGA was completely removed by
dialyzing
until the conductivity reached 0 mS or 12-20 volume changes.
16
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
[0081] Step 16: The solution from Step 15 was lyophilized into a keratin
protein cake of alpha
kerateine. Here, the lyophilization step was to bulk freeze the solution to -
40 C quickly then
apply a vacuum until the containment vessel containing the protein reached 250
tort. Heat was
applied in a step-wise fashion to bring the material first to 0 C, then to 25
C, then to 37 C
while maintaining 250 ton. The temperature was not allowed to exceed 37 C in
order to
prevent degradation during the drying process.
[0082] Step 17: The keratin protein cake from Step 16 was ground using a
pharmaceutical mill
with a mesh size of 500 or 1000 microns. The ground protein was deionized to
better allow
further processing. The ground protein was then placed in sterile bags and
stored until
reconstitution.
[0083] Production of kerateine hydrogels
Kerateine hydrogels were prepared for analysis by carefully weighing the
appropriate keratin
lyophilized powder. The powders were diluted in sterile water to generate the
described percent
mass to volume ratio. These solutions were placed in a 37 C incubator
overnight before
analysis.
[0084] For rheological data, measurements were performed on a Bohlin CS-10
Rotational
Rheometer. Solutions that were able to flow from the incubation tubes were
measured in a
14mm cup and bob apparatus. Solutions that were too complexed to flow were
measured
between a 20rrun plate and plate apparatus with a 15mm gap. All measurements
were performed
at 25 C. Preliminary stress sweep test were performed on each sample to
determine the linear
region within the viscoelastic response. The frequency dependence of the
viscoelastic properties
of the kerateine gels were measured at 25 Pa. The elastic modulus, viscous
modulus, and
complex viscosity were measured and reported in Tables 2 and 3, below.
[0085] Table 2. Rheological values of kerateine gels (n=3)
20% from Richter et al. 2011 8% 20%
Frequency
(Hz) 1 1 1
G'(Pa) 8870+/-580 1590+/-1454 19408+/-5314.5
17
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
G''(Pa) 550+/-20 45.3+1-33.0 1663.8+1-621.6
qt(Pa) 87.8+/-3.6 223.6+/-204.4 2738.6+/-751.8
[00861 Presented in Table 2 are the rheological values for a 20% kerateine gel
from Richter et at.
2011 (lane 1), and kerateine hydrogels prepared as in this example at 8%
kerateine (lane 2) and
at 20% (lane 3). Of note, the rheological data reported from Richter et al.
demonstrated low
standard deviations versus the real values for all the parameters tested. It
is expected that the
kerateine in the hydrogels retains free sulfhydryl groups capable of forming
disulfide bonds at
random. The random formation of disulfide bonds produces heterogeneity beyond
complexing
(as opposed to keratose hydrogels which rely solely on complexing to form
structure). Thus, the
heterogeneity in structure of the hydrogel leads to variable rheological data
from sample to
sample. Accordingly, the rheological data from a kerateine hydrogel should
exhibit a high level
of standard deviation. The relatively low variability in the gels reported
from Richter suggests
that the structure is very uniform throughout the different samples with less
random disulfide
bonding. Conversely, the data for 8% gels prepared as presented herein produce
very high
standard deviations when the various rheological parameters are tested. The 8%
kerateine gels
exhibited a high standard deviation in measurements for dynamic complex
modulus (G*),
dynamic elastic/storage modulus (G'), dynamic complex viscosity (1*), and
dynamic
viscous/loss modulus (G"). These data demonstrated that the 8% hydrogels
produced herein
exhibit a less uniform, but more stable structure with more random disulfide
bonding than the
20% gels reported in the art. Further, the data for 20% gels prepared as
presented herein
exhibited very high standard deviations when the various rheological
parameters are tested. The
20% kerateine gels exhibited a very high standard deviation in measurements
for dynamic
complex modulus (G*), dynamic elastic/storage modulus (G'), dynamic complex
viscosity (ri*),
and dynamic viscous/loss modulus (G"). These data demonstrate that the 20%
hydrogels
produced herein also exhibit a less uniform, but more stable structure with
more random
disulfide bonding than the 20% gels reported in the art.
(0087) Table 3. Rheological values of kerateine gels (n=3)
20% from Richter et al. 2011 10 % 15% 20%
Frequency 1 1 1 1
18
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
(Hz)
GlPa) 8870+1-580 3140+/-332 10680+1-1007 21816+/-6687
G"(Pa) 550+/-20 280+1-30 1716+1-88 4949+/-1843
n*(Pas) 87.8+1-3.6 443+/-47 1521+1-142 3145+1-967
100881 Presented in Table 3 are the rheological values for a 20% kerateine gel
from Richter et al.
2011 (lane 1), and kerateine hydrogels prepared as in this example at 10%
kerateine (lane 2) and
at 15% (lane 3) and at 20% (lane 3). Of note, the rheological data reported
from Richter et al.
demonstrated low standard deviations versus the real values for all the
parameters tested. It is
expected that the kerateine in the hydrogels retains free sulfhydryl groups
capable of forming
disulfide bonds at random. The random formation of disulfide bonds produces
heterogeneity
beyond complexing (as opposed to keratose hydrogels which rely solely on
complexing to form
structure). Thus, the heterogeneity in structure of the hydrogel leads to
variable rheological data
from sample to sample. Accordingly, the rheological data from a kerateine
hydrogel should
exhibit a high level of standard deviation. The relatively low variability in
the gels reported from
Richter suggests that the structure is very uniform throughout the different
samples with less
random disulfide bonding. Conversely, the data for 10% gels prepared as
presented herein
produce very high standard deviations when the various theological parameters
are tested. The
10% kerateine gels exhibited a very high standard deviation in measurements
for dynamic
complex modulus (G*), dynamic elastic/storage modulus (G'), dynamic complex
viscosity (11*),
and dynamic viscous/loss modulus (G"). These data demonstrated that the 10%
hydrogels
produced herein exhibit a less uniform, but more stable structure with more
random disulfide
bonding than the 20% gels reported in the art. Further, the data for 15% gels
prepared as
presented herein exhibited very high standard deviations when the various
rheological
parameters are tested. The 15% kerateine gels exhibited high standard
deviations in
measurements for dynamic complex modulus (G*), dynamic elastic/storage modulus
(G'),
dynamic complex viscosity (ri*), and dynamic viscous/loss modulus (G"). These
data
demonstrate that the 15% hydrogels produced herein also exhibit a less
uniform, but more stable
structure with more random disulfide bonding than the 20% gels reported in the
art. Moreover,
the data for 20% gels prepared as presented herein exhibited very high
standard deviations when
the various rheological parameters are tested. The 20% kerateine gels
exhibited a high standard
19
CA 02845267 2014-02-13
WO 2013/025941 PCT/US2012/051215
deviation in measurements for dynamic complex modulus (G*), dynamic
elastic/storage modulus
(G'), dynamic complex viscosity (ti*), and dynamic viscous/loss modulus (G").
These data
demonstrate that the 20% hydrogels produced herein also exhibit a less
uniform, but a more
stable structure with more random disulfide bonding than the 20% gels reported
in the art.
